Tirzepatide is a medication approved by the FDA for treating type 2 diabetes and, more recently, for managing obesity under the brand names Zepbound and Mounjaro
Among patients with obesity undergoing bariatric surgery, the proportion taking a GLP-1 receptor agonist in the year before their procedure rose sharply between 2018 and 2023, researchers reported
Averaged LD cycle and total 24-h respiratory exchange ratio and energy expenditure were analysed per genotype and per sex
GLP-1 receptor agonists have been shown to lower blood pressure, particularly systolic blood pressure, contributing to cardiovascular health
The practical recommendation: use 5mg vials during the first eight weeks of dose escalation when weekly consumption is low
If fatigue becomes severe or if youre experiencing additional symptoms, such as dizziness or chest pain, seek immediate medical attention